Sarah E. Buerki

Sarah E. Buerki

Auto-generated profile, based on publicly available information

Sarah E. Buerki

Department of Neuropediatrics, University Children's Hospital Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JLJohannes R Lemke
Johannes R Lemke
DLDennis Lal
Dennis Lal
EREva M Reinthaler
Eva M Reinthaler
ISIsabelle Steiner
Isabelle Steiner
MNMichael Nothnagel
Michael Nothnagel
SSSarah von Spiczak
Sarah von Spiczak

1 May 2015 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SGSebastian Grunt
Sebastian Grunt
LMLea Mazenauer
Lea Mazenauer
SBSarah E. Buerki
Sarah E. Buerki
EBEugen Boltshauser
Eugen Boltshauser
AMAndrea Capone Mori
Andrea Capone Mori
MSMaja Steinlin
Maja Steinlin
BACKGROUND AND OBJECTIVES: Neonatal arterial ischemic stroke (NAIS) is associated with considerable lifetime burdens such as cerebral palsy, epilepsy, and cognitive impairment. Prospective epidemiologic studies that include outcome assessments are scarce. This study aimed to provide information on the epidemiology, clinical manifestations, infarct characteristics, associated clinical variables, treatment strategies, and outcomes of NAIS in a prospective, population-based cohort of Swiss children. METHODS: This prospective study evaluated the epidemiology, clinical manifestations, vascular territories, associated clinical variables, and treatment of all full-term neonates diagnosed with NAIS and born in Switzerland between 2000 and 2010. Follow-up was performed 2 years (mean 23.3 months, SD 4.3 months) after birth. RESULTS: One hundred neonates (67 boys) had a diagnosis of NAIS. The NAIS incidence in Switzerland during this time was 13 (95% confidence interval [CI], 11–17) per 100 000 live births. Seizures were the most common symptom (95%). Eighty-one percent had unilateral (80% left-sided) and 19% had bilateral lesions. Risk factors included maternal risk conditions (32%), birth complications (68%), and neonatal comorbidities (54%). Antithrombotic and antiplatelet therapy use was low (17%). No serious side effects were reported. Two years after birth, 39% were diagnosed with cerebral palsy and 31% had delayed mental performance. CONCLUSIONS: NAIS in Switzerland shows a similar incidence as other population-based studies. About one-third of patients developed cerebral palsy or showed delayed mental performance 2 years after birth, and children with normal mental performance may still develop deficits later in life.

1 July 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ALAnna Lehman
Anna Lehman
STSamrat Thouta
Samrat Thouta
GMGrazia M.S. Mancini
Grazia M.S. Mancini
SNSakkubai Naidu
Sakkubai Naidu
MSMarjon van Slegtenhorst
Marjon van Slegtenhorst
SVSuzanne Vercauteren
Suzanne Vercauteren

1 August 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
IGIlaria Guella
Ilaria Guella
MMMarna B. McKenzie
Marna B. McKenzie
DEDaniel M. Evans
Daniel M. Evans
SBSarah E. Buerki
Sarah E. Buerki
ETEric B. Toyota
Eric B. Toyota
SVSuzanne Vercauteren
Suzanne Vercauteren

1 January 2016 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
AMA. Müller
A. Müller
IHI. Helbig
I. Helbig
CJC. Jansen
C. Jansen
TBT. Bast
T. Bast
RGR. Guerrini
R. Guerrini
GKG. Kluger
G. Kluger

6 August 2014 in European Radiology
Verified
Journal Article
Closed access
PDF file
JAJerome Aellen
Jerome Aellen
EAEugenio Abela
Eugenio Abela
SBSarah E. Buerki
Sarah E. Buerki
RKRaimund Kottke
Raimund Kottke
ESElisabeth Springer
Elisabeth Springer
RVRajeev K. Verma
Rajeev K. Verma